|
|
|
|
Vol. 298, Issue 1, 188-196, July 2001
2-Adrenergic Stimulation in Heart Failure
Cardiology Section, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina
| |
Abstract |
|---|
|
|
|---|
The
2-adrenergic receptor (
2-AR)-mediated
increase in cardiac L-type Ca2+ current (ICa,L)
has been documented in normal subjects. However, the role and mechanism
of
2-AR activation on ICa,L in heart failure (HF) are unclear. Accordingly, we compared the effect of zinterol (ZIN), a highly selective
2-AR agonist, on
ICa,L in isolated left ventricular cardiomyocytes obtained
from normal control and age-matched rats with HF induced by left
coronary artery ligation (4 months). ICa,L was measured by
using the whole-cell voltage-clamp technique. In normal myocytes,
superfusion of ZIN (10
5 M) caused a 21% increase in
ICa,L (9.21 ± 0.24 versus 7.59 ± 0.20 pA/pF)
(p < 0.05). In HF myocytes, the same concentration of ZIN produced a significantly greater increase (30%) in
ICa,L (6.20 ± 0.24 versus 4.75 ± 0.17 pA/pF)
(p < 0.01). This ZIN-induced increase in
ICa,L was further augmented in both normal and HF myocytes
(normal: 59 versus 21%; HF: 71 versus 30%) after the incubation of
myocytes with pertussis toxin (PTX, 2 µg/ml, 36°C, 6 h). These
effects were not modified by the incubation of myocytes with CGP-20712A
(3 × 10
7 M), a
1-AR antagonist, but
were abolished by pretreatment of myocytes with ICI-118551
(10
7 M), a
2-AR antagonist. In addition,
all of the effects induced by ZIN were completely prevented in the
presence of an inhibitory cAMP analog, Rp-cAMPS (100 µM, in the
patch-pipette solution). In conclusion,
2-AR
activation stimulates L-type Ca2+ channels and increases
ICa,L in both normal and HF myocytes. In HF,
2-AR activation-induced augmentation of
ICa,L was increased. These effects are likely to be
mediated through a cAMP-dependent mechanism and coupled with both
stimulatory G protein and PTX-sensitive G protein.
| |
Introduction |
|---|
|
|
|---|
-Adrenergic
receptor (AR) stimulation modulating cardiac L-type
Ca2+ current (ICa,L) plays
an important role in the positive inotropic response to
-AR
stimulation, and it has been shown to be impaired in heart failure (HF)
myocytes (Richard et al., 1998
). Besides
1-AR
stimulation of L-type Ca2+ channels, which is
mediated by a cAMP/PKA-signaling mechanism, the
2-AR-mediated increase in cardiac
ICa,L has been documented in normal subjects
(Xiao and Lakatta, 1993
; Cerbai et al., 1995
; Xiao et al., 1995
;
Skeberdis et al., 1997
). It is proposed that cardiac
2-AR couples with both
Gs and Gi protein (Xiao et
al., 1999
). The
2-AR-coupled
Gi activation functionally localizes the
Gs-mediated adenylyl cyclase-cAMP/PKA signaling
(Zhou et al., 1997
), thereby negatively regulating the
Gs-mediated ICa,L and contractile response in the heart (Xiao et al., 1995
). Chronic HF is
associated with a marked increase in Gi protein
and a selective down-regulation of
1-AR
(higher
2/
1). The
exaggerated
2-AR/Gi signaling may contribute to the HF-associated dysfunction of
-AR stimulation (Xiao et al., 1999
). Previously, Bristow et al. (1989)
reported a diminished
2-AR-mediated cardiac
response by documenting a decreased adenylate cyclase stimulation.
However, we and other investigators have observed an increased positive
inotropic responsiveness to
2-AR stimulation
in dogs with pacing-induced HF (Altschuld et al., 1995
; Cheng et al.,
1998
) and in left ventricular (LV) myocytes from rats with
infarction-induced HF (Ukai et al., 1999
). This effect may be due to a
2-AR stimulation-induced alteration in the
regulation of the Ca2+ channel. However, the role
and mechanism of
2-AR activation on
ICa,L in HF have not been previously assessed.
Accordingly, the purpose of this study was to compare the effect of
2-AR stimulation on cardiac
ICa,L in LV myocytes of normal rats and rats with
HF and to determine the underlying cellular mechanism. Our results
indicate that the
2-AR activation-induced augmentation of ICa,L was enhanced in the HF
myocytes. These effects are likely to be mediated through a
cAMP-dependent mechanism and coupled with both Gs
and PTX-sensitive Gi protein.
| |
Experimental Procedures |
|---|
|
|
|---|
Experimental Heart Failure Model. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication 85-23, revised 1985).
The rat HF model was prepared by surgical ligation of the coronary artery (Dixon et al., 1990Isolation of LV Myocytes.
Myocytes were enzymatically
disassociated by Langendorff perfusion as we previously described
(Suzuki et al., 1998
). Care was taken to excise the infarct scar in the
heart of each rat with MI before the final enzymatic digestion step.
With this technique, the yield of viable myocytes was greater than 80%
from both control rats and rats with MI. The cells were used within
10 h.
Electrophysiological Measurement.
Membrane calcium current
was recorded at 22 to 23°C with the whole-cell patch-clamp technique
(Hamill et al., 1981
). Axopatch 200A amplifier (Axon Instruments,
Foster City, CA) was interfaced with a 12-bit A/D-D/A converter
(Digidata 1200; Axon Instruments). PClamp software (PClamp 6.02; Axon
Instruments) was used for data acquisition and analysis. Data were
filtered by means of a 5-kHz low-pass filter and digitized at 5 kHz.
when filled with pipette (internal) solution.
Liquid junction potentials (<5 mV) were corrected before the pipette
touched the cell. The formation of a G
seal was followed by
electronic compensation of the electrode capacitance. Then the cell
membrane was ruptured by means of gentle suction to establish the
whole-cell configuration. Compensation of the membrane capacitance and
series resistance was performed to minimize the duration of the
capacitive transient. The membrane capacitance was measured, before
compensation, by a 10-mV depolarizing step from a holding potential of
80 to
70 mV and integrating the area under the current transient
calculated by the following formula:
|
c is the decay time constant of
membrane capacitance, I0 is the
maximum capacitance current value,
Vm is the amplitude of the voltage
steps, and I
is the amplitude of
the steady-state current. The membrane capacitance was used as an index
to normalize ICa,L for cell size. The series
resistance was calculated as follows:
|
80 mV. Ca2+
currents were elicited by stepping the membrane voltage from the
holding potential to the 0 mV testing potential for 200 ms at 0.1 Hz.
To avoid contamination by fast sodium channel activation and to reduce
the run-down of ICa,L, a brief (60 ms in
duration) prepulse was applied to
40 mV before stepping to the test
potential. The average peak ICa,L run-down was
about 10 to 20% during the 30 min after the initial measurement. Most
(80%) of the run-down occurred within the initial 8 to 10 min. Thus, a
time window of 10 to 30 min after the initial recording was chosen to
measure ICa,L with respect to drug effects (Xiao
and Lakatta, 1993
35 to +60 mV at 5-mV increments
and 0.1 Hz.
Solutions.
The composition of the pipette solution and that
of the recording bath solution were chosen to allow isolation of ion
flow through Ca2+ channels by blocking other
ionic currents. Initially, the myocytes were superfused with a modified
Tyrode's solution containing 137 mM NaCl, 5.4 mM KCl, 1.2 mM
MgSO4, 15 mM glucose, 10 mM HEPES, and 1.5 mM
CaCl2. The pH was adjusted to 7.4, with NaOH at
20 to 22°C. After formation of a G
seal, the perfusion buffer was changed to a patch recording bath solution, i.e.,
Na+- K+-free Tyrode's
solution in which tetraethylammonium chloride was substituted
for NaCl, 50 µM tetrodotoxin was added to eliminate sodium current,
and KCl was replaced by CsCl and 3 mM 4-aminopyridine to abort the
potassium current. The solution was gassed with 100% O2. The internal solution for the pipette
contained 140 mM cesium aspartate, 1.0 mM MgCl2,
3 mM Na2ATP, 0.4 mM GTP, 10 mM EGTA, and 5 mM
HEPES. The pH was adjusted to 7.2 (with titrated CsOH).
Materials. Zinterol {MJ-9184-1; N-(5(2-[1,1 dimethyl-2-phenyl-ethyl] amino)-1-hydroxyethyl)-2-hydroxyphenyl]-monohydrochloride} was provided by Bristol-Myers Squibb Co. (Princeton, NJ); ICI-118,551 and CGP-20712A (CGP) was obtained from RBI/Sigma, Natick, MA; and Rp-cAMPS was from Biology Life Science Institute, La Jolla, CA. Other agents were obtained from Sigma, St. Louis, MO.
Statistical Analysis.
Data are presented as mean ± S.E.M. Statistical comparisons were performed with Student's
t test or analysis of variance. A p value of
<0.05 was considered significant. Prism 3.0 (GraphPad software;
GraphPad, San Diego, CA) was used for the
concentration-ICa,L relationship nonlinear
regression analysis. As previously described by Robberecht et al.
(1983)
and Lands et al. (1967)
, the Hill equation may allow us modeling
cooperatively between multiple receptor sites on each cardiomyocyte
with respect to
2-AR agonist (ZIN) binding.
Thus, data were fitted with the Hill equation. The best fit by the Hill
equation was also compared with a fit by one-site competition equation.
| |
Results |
|---|
|
|
|---|
Verification of Experimental HF
The general hemodynamic and ICa,L features
in the rats with MI are presented in Table
1. LV end-diastolic pressure was
increased 5-fold; left ventricular systolic pressure, LV
dp/dtmax, and LV dp/dtmin
were significantly decreased. The rate of LV relaxation was slowed, as
indicated by a significant increase in the time constant of isovolumic
LV pressure decay (
, 196%, p < 0.05).
|
All of the animals with MI had clear evidence of HF (anorexia, edema, and pulmonary congestion). There were no significant changes in body weight (593 ± 9 versus 598 ± 7 g, p = N.S.), whereas the heart weight (2.21 ± 0.03 versus 1.62 ± 0.02 g, p < 0.05), the calculated ratio of LV-to-body weight (2.50 ± 0.04 versus 1.85 ± 0.03 g/kg, p < 0.05), and the wet lung-to-body weight ratio (4.83 ± 0.10 versus 2.87 ± 0.07 g/kg, p < 0.05) were all significantly increased in the rats with MI. In the myocytes of rats with HF, the membrane capacitance was significantly increased (66%), indicating an existence of hypertrophy of the myocytes. After normalized by the membrane capacitance, the current density was significantly lower than that of the normal myocytes (62%, p < 0.01), indicating an absolute reduction of ICa,L.
In addition, the response of ICa,L to
-adrenergic receptor stimulation in HF myocytes was significantly
attenuated. The exposure to isoproterenol (ISO,
10
7 M) increased the
ICa,L by 120 ± 14% (p < 0.05, n = 10) in the normal myocytes. However, in the
myocytes of rats with HF, the increase in ICa,L
with ISO was only half (56 ± 8%, p < 0.05, n = 9). The current was blocked by nifedipine (5 × 10
6 M), a Ca2+ channel
blocker, consistent with the characteristics of
ICa,L. We previously showed that in rats with MI,
the contractility of the myocytes was also markedly impaired (Ukai et
al., 1999
). These findings demonstrated the existence of an established
HF in this model.
Increased Responses of ICa,L to
2-AR
Stimulation in HF Myocytes
Figure 1 shows typical
ICa,L responses to
2-AR
stimulation in normal (Fig. 1A) and HF myocytes (Fig. 1B). Superfusion
of ZIN, a highly selective
2-AR agonist
(10
5 M), caused significant increases in peak
ICa,L in normal myocytes (21%, 2.13 ± 0.19 versus 1.75 ± 0.15 nA, p < 0.05, n = 21). In HF myocytes, ZIN caused a greater increase
in ICa,L (30%, 2.18 ± 0.14 versus
1.66 ± 0.10 nA, p < 0.01, n = 24). The ZIN-induced absolute increases in ICa,L
between normal (0.38 ± 0.05 nA) and HF cells (0.52 ± 0.06 nA) are statistically significant (p < 0.05). After
normalized by the membrane capacitance, the ZIN-induced increases in
ICa,L remained statistically different in both
normal (9.21 ± 0.24 versus 7.59 ± 0.20 pA/pF) and HF cells
(6.20 ± 0.24 versus 4.75 ± 0.17 pA/pF). This current was
blocked by nifedipine (5 × 10
6 M). Figure
1, C and D, shows the current-voltage relations for the response of
ICa,L to ZIN in normal myocytes and in those of rats with HF. The stimulatory effects of ZIN on
ICa,L were not accompanied by a significant
change in the voltage dependence of peak ICa,L
amplitude in normal and HF myocytes.
|
Concentration-Dependent Activation of ICa,L by ZIN
Concentration-response curves of ICa,L to
ZIN of myocytes from normal rats and rats with HF are compared in Fig.
2. Smooth curves were obtained by fitting
the data with the Hill equation. The dose-response curve was shifted
upward, and the half-maximal activation concentration
(EC50) of the HF myocytes was lower than that of
the normal myocytes (168 versus 688 nM). The Hill coefficient of ZIN
(0.83 in normal and 0.88 in HF cells) was similar as reported by
Robberecht et al. (1983)
. Similarly, with one-site competition equation, the half-maximal activation concentration was 733 nM for
normal and 174 nM for HF myocytes. There were no significant differences between the best fits achieved by both Hill and one-site competition equation.
|
Effects of
1- and
2-AR Blockade on
ZIN-Induced Increase in ICa,L
The affinity of ZIN for
2-AR is
approximately 50 times over
1-AR
(disassociation constant is 20 versus 1000 nM) (Minneman et al., 1979
).
ZIN at 10
5 M has been shown to induce maximal
response in cell contraction [Ca2+]i transient and
ICa,L in rat cardiomyocyte (Xiao and Lakatta, 1993
; Xiao et al., 1995
). This high concentration of ZIN may also stimulate
1-AR or
1-AR or work through nonadrenergic receptor system (Edwards and Whitaker-Azmitia, 1987
; Parfitt and Bickford-Wimer, 1990
). To determine the potential mechanism, we preincubated the myocytes with CGP (a
1-AR antagonist, 3 × 10
7 M) or ICI-118551 (ICI, a
2-AR antagonist, 10
7
M) for 20 min, and ZIN was given in the presence of CGP or ICI. As
shown in Fig. 3, after using CGP to block
the
1-AR, the ZIN-induced increase in
ICa,L persisted in both normal (7.51 ± 0.40 versus 6.20 ± 0.30 pA/pF, p < 0.05, n = 4) and HF cells (5.16 ± 0.30 versus 4.03 ± 0.20 pA/pF, p < 0.05, n = 4). In
contrast, as displayed in Fig. 4, after
preincubation with the
2-AR blocker, ICI, the ZIN-induced increase in ICa,L was abolished in
both normal (7.22 ± 0.30 versus 7.07 ± 0.30 pA/pF,
p = N.S., n = 4) and HF cells (4.52 ± 0.35 versus 4.51 ± 0.38 pA/pF, p = N.S., n = 4), indicating that ZIN increased
ICa,L through
2-AR, not
1-AR,
1-AR, or other nonadrenergic system.
|
|
Effect of Gi Protein Blockade-Induced Increase in ICa,L
Distinct from
1-AR in signal
transduction,
2-AR couples with both
Gs and Gi proteins (Xiao et
al., 1999
). To define the role of Gi protein in
2-AR stimulation of
ICa,L, we pretreated the myocytes with PTX (2 µg/ml, 36°C, 6 h). The adequacy of the complete blockage of
inhibitory Gi protein in PTX-treated cells was
routinely verified by the loss of the ability of acetylcholine (ACh,
10
5 M) to reverse the stimulatory effect of ISO
on ICa,L.
Effect of ACh on Response to ISO.
ACh is generally thought to
activate PTX-sensitive Gi protein and counteract
the Gs-activating effect by
-AR stimulation. PTX-treated myocytes were compared with myocytes that had been kept at
36°C in the absence of PTX for an equal time. In the normal cells,
ISO (10
7 M) increased
ICa,L by 120 ± 14%, and further
application of ACh (10
5 M) decreased the
ISO-induced augmentation in ICa,L to 84 ± 10% (p < 0.05, n = 4). With PTX
pretreatment, in the normal cells, the reduction of ISO response on
ICa,L caused by ACh was prevented (an increase of
116 ± 12%, p = N.S., n = 4).
This is consistent with the observations of Lauer et al. (1992)
. In HF
cells, the increase of ICa,L by ISO was markedly
attenuated (56 ± 8%), and the addition of ACh almost prevented
the ISO-induced increase in ICa,L (10 ± 8%, p = N.S., n = 4). Thus, compared
with normal cells, the inhibition effect of ACh on ISO response in HF
cells was significantly augmented (82 versus 30%, p < 0.05, n = 4). In the PTX-treated HF cells, the
reduction of ISO response caused by ACh was totally abolished
(increases of 93 ± 14 versus 95 ± 10%, p = N.S., n = 4). This observation is in line with the
phenomenon of PTX-restoring ISO response of contraction in
cardiomyocytes from patients with HF reported by Brown and Harding
(1992)
.
|
Effects of ZIN on Response to a
1-AR Agonist.
In a subgroup of animals, we examined the effect of ZIN on
ICa,L response after a
1-AR
stimulation with norepinephrine (NE, 10
7 M). We
found that in normal myocytes, NE caused a significant increase in
ICa,L (78%, 14.05 ± 1.50 versus 8.17 ± 1.00 pA/pF, p < 0.05, n = 4). The
addition of ZIN (10
5 M) caused an attenuation
(43%) in NE-induced ICa,L increase (10.53 ± 1.30 versus 8.17 ± 1.00 pA/pF, p < 0.05, n = 4). In contrast, in HF myocytes, compared with
normal myocytes, NE caused a much smaller increase in
ICa,L (17%, 5.39 ± 1.20 versus 4.62 ± 0.90 pA/pF, p < 0.05). The application of ZIN
caused an additive increase in ICa,L
(approximately 8%, from 5.39 ± 1.20 to 5.75 ± 1.30 pA/pF, p < 0.05, n = 4). Thus, it appears
that in normal cardiomyocytes, ZIN had an inhibitory effect when
applied after the effect of
1-AR stimulation
had developed; but in HF cells, ZIN exhibited a stimulatory action on
ICa,L, suggesting an altered interaction between
1- and
2-AR
stimulation in HF cells.
Effect of Gs-cAMP Pathway Blockade on ZIN-Induced Increase in ICa,L
Since accumulating evidence indicates that the effect of
-AR
stimulation on cardiac ICa,L is mediated by a
cAMP-dependent mechanism (Zhou et al., 1997
), we further examined the
role of cAMP-dependent PKA activation in
2-AR
stimulation of ICa,L by including an inhibitory
cAMP analog Rp-cAMPS (10
4 M) in pipette
solution to block the stimulatory Gs protein-cAMP pathway. As shown in Fig. 6, with
intracellular application of Rp-cAMPS, basal
ICa,L was decreased about 20%, which is
consistent with previous observations (Zhou et al., 1997
). However,
under this condition, ZIN-induced ICa,L increase
was prevented in both normal (6.06 ± 0.32 versus 6.17 ± 0.25 pA/pF, p = N.S., n = 6) and HF
(3.78 ± 0.06 versus 3.88 ± 0.10 pA/pF, p = N.S., n = 4) myocytes.
|
| |
Discussion |
|---|
|
|
|---|
The present study demonstrated, for the first time, that
2-AR stimulation of
ICa,L by ZIN was enhanced in LV myocytes of rats
with infarction-induced heart failure. These effects were mediated
through a cAMP-dependent mechanism and coupled with both stimulatory
Gs protein and PTX-sensitive inhibitory
Gi protein.
Effects and Possible Mechanism of ZIN on ICa,L.
It
has been increasingly recognized that
1- and
2-AR coexist in the heart. In large mammal
hearts,
2-AR may account for approximately
40% of the total
-AR number, while in small animals, cardiac
2-ARs are less abundant. The reported ratio of
1-/
2-AR was
92-80/8-20 in adult rat hearts (Cerbai et al., 1995
; Kuznetsov et al., 1995
).
-AR stimulation modulating cardiac
ICa,L plays an important role in the positive
inotropic response to
-AR stimulation.
5 M in normal cells. This effect was
completely abolished by
2-AR antagonist, but
not by the
1-AR antagonist, indicating that
the alterations of ICa,L following ZIN
superfusion were due to
2-AR activation.
Furthermore, we found that the effect of ZIN was enhanced by
pretreatment of the myocytes with PTX, indicating a negative modulation
by Gi. An inhibitory cAMP analog, Rp-cAMPS,
blocked the ZIN-induced increase in ICa,L. These
findings suggest that the cardiac
2-adrenergic
signal transduction is dual coupling to both Gs
and Gi protein (Steinberg, 1999
2-AR was stimulated alone. This discrepancy
may be due to a much smaller dose of ZIN (50 nM, 200 times smaller than
the dosage used by us and others) used in their study.
A novel finding in the present study is that the responsiveness of
ICa,L to
2-AR
stimulation was enhanced after HF. Although
2-AR-dependent signals represent only a
relatively minor component of catecholamine responsiveness under normal
physiological conditions,
2-ARs assume
increased importance as a mechanism for inotropic support in the
failing heart. Since there is a selective down-regulation of
1-ARs with resultant increase in
2/
1 ratio in HF.
In the present study, we demonstrated that in HF myocytes, the
ICa,L was significantly decreased, and its
response to
-AR stimulation (ISO 10-7 M) was
also markedly blunted (56% versus 120% increment, p < 0.05). However, the response to ZIN (10-5 M)
was significantly enhanced (30% versus 21%). The dose-response curve
shifted upward, and the half-maximal activation concentration (EC50) was significantly decreased (168 versus
688 nM), indicating an increased responsiveness to
2-AR stimulation. After preincubation of the
myocytes with PTX to block Gi, the increment in
ICa,L by ZIN was further augmented.
These observations are supported by several recent findings (Altschuld
et al., 1995
2-AR stimulation with ZIN than were normal
myocytes. In addition, we have previously demonstrated that
2-AR stimulation by ZIN caused an enhanced
augmentation in ventricular contractility in conscious dogs with
pacing-induced HF (Cheng et al., 1998
5 M) caused an
enhanced positive inotropic effect associated with an increased
[Ca2+]i transient.
However, our observations are not likely to agree with the findings in
the failing human heart by Bristow et al. (1989)
2-AR-mediated cardiac response by
documenting a decreased adenylate cyclase stimulation (32% reduction
in cAMP production). It is evident that
2-AR
stimulation-induced increase in cAMP is not coupled to contractility,
Ca2+ dynamics, and phospholamban phosphorylation
(Xiao et al., 1994
2-AR
stimulation. Since the acute effect of ZIN on
ICa,L was not examined in the Bristow et al.
(1989)
2-AR
stimulation in the human heart.
Since
2-AR couples with both
Gs and Gi protein, the
increased Gi protein in HF may be expected to
have a negative modulation on ZIN-induced changes in
ICa,L. Why have others (Altschuld et al., 1995
2-AR density on the membrane of HF cells and a
differential cAMP compartmentation via altered signal transduction may
contribute to our current findings.
Consistent with previous observations, in our MI rats, the cardiac
hypertrophy was established, and the myocytes from these hearts were
enlarged. It has been reported that the synthesis of
2-AR closely parallels cell growth (Cerbai et
al., 1995
2-AR density in MI rats may be associated with
increased
2-AR numbers per cell. In fact, the
increase of
2-AR density has been demonstrated
in LV of dogs with pacing-induced HF (Kiuchi et al., 1993
2-AR per cell, which parallels the increase in
cell size. It is interesting to note that a similar observation was
also obtained in neonatal myocytes. Kuznetsov et al. (1995)
2-AR density per neonatal myocyte was
5-fold higher than per adult myocyte, and ZIN evoked a substantial increase in cAMP accumulation and a greater physiological effect on
excitation-contraction coupling in neonatal myocytes in comparison with
adult myocytes. The PTX-sensitive Gi protein was
found higher in neonatal than in adult rat ventricle (Bartel et al.,
1996
1- and
2-AR stimulation and studies of others (Xiao
et al., 1994
2-AR to other important signaling pathways
such as the mitogen-activated protein kinase (Daaka et al., 1997
2-AR stimulation (Hohl and Li, 1991
2-AR stimulation does
not produce a generalized cAMP accumulation in cardiomyocytes, but,
rather, is confined in regions localized to subsarcolemmal compartments
(Yanagisawa et al., 1989
2-AR
activation is differentially compartmentalized in normal and diseased
state of the heart.
The functional significance of
2-AR
stimulation remains controversial (Billman et al., 1997
2-AR stimulation was enhanced in HF. This
enhanced response could cause more Ca2+ influx
into cardiomyocytes, enhance excitation-contraction coupling, and thus
improve myocardial contractile performance in HF. Liggett et al. (2000)
2-AR up to 100-fold in the mouse heart causes
significant increased cardiac contractile force without any
cardiomyopathic consequences during the 1-year study period. A gene
therapy approach with overexpression of
2-ARs
has also been suggested (Lefkowitz et al., 2000
2-AR activation
stimulates L-type Ca2+ channel and increases
ICa,L in both normal and HF myocytes. In rats
with infarction-induced HF,
2-AR
activation-induced augmentation of ICa,L was
increased. These effects are likely to be mediated through a
cAMP-dependent mechanism and coupled with both stimulatory Gs protein and PTX-sensitive inhibitory
Gi protein. This finding is likely to be the
underlying mechanism for the improved inotropic responsiveness to
2-AR stimulation in the failing heart.
| |
Acknowledgments |
|---|
We gratefully acknowledge the help of Drs. J. Mu and R.-L. Wu on patch-clamp technique. We also acknowledge the expert editorial review of Dr. Donna Garrison, the computer programming of Dr. Ping Tan, the technical assistance of Ellen Tommasi and Mike Cross, and the secretarial assistance of Amanda Burnette.
| |
Footnotes |
|---|
Accepted for publication March 19, 2001.
Received for publication December 26, 2000.
This study was supported in part by grants from the National Institutes of Health (HL45258, HL53541, and HL12335-01A1) and the American Heart Association (9640189N). Dr. C. P. Cheng is an established investigator of the American Heart Association. An abstract of this work was presented at the 1999 American Heart Association Meeting.
Address correspondence to: Che-Ping Cheng, M.D., Ph.D., Wake Forest University School of Medicine, Cardiology Section, Medical Center Blvd., Winston-Salem, NC 27157-1045. E-mail: ccheng{at}wfubmc.edu
| |
Abbreviations |
|---|
AR, adrenergic receptor; ICa,L, L-type Ca2+ current; HF, heart failure; PKA, protein kinase A; LV, left ventricular; LV dp/dtmax and dp/dtmin, maximum and minimum time derivative of LVP, respectively; PTX, pertussis toxin; MI, myocardial infarction; ZIN, zinterol; CGP, CGP-20712A; ISO, isoproterenol; ICI, ICI-118551; Ach, acetylcholine; NE, norepinephrine; [Ca2+]i, intracellular calcium.
| |
References |
|---|
|
|
|---|
and Ca2+ channels in guinea pig ventricular myocytes.
Am J Physiol
273:
H1669-H1676This article has been cited by other articles:
![]() |
Z.-S. Zhang, H.-J. Cheng, K. Onishi, N. Ohte, T. Wannenburg, and C.-P. Cheng Enhanced Inhibition of L-type Ca2+ Current by {beta}3-Adrenergic Stimulation in Failing Rat Heart J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1203 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dorian Antiarrhythmic Action of{beta}-Blockers: Potential Mechanisms Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4_suppl): S15 - S22. [Abstract] [PDF] |
||||
![]() |
G. K. R. Soppa, R. T. Smolenski, N. Latif, A. H. Y. Yuen, A. Malik, J. Karbowska, Z. Kochan, C. M. N. Terracciano, and M. H. Yacoub Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1468 - H1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Hoogland and P. Saggau Facilitation of L-Type Ca2+ Channels in Dendritic Spines by Activation of {beta}2 Adrenergic Receptors J. Neurosci., September 29, 2004; 24(39): 8416 - 8427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Morimoto, H. Hasegawa, H.-J. Cheng, W. C. Little, and C.-P. Cheng Endogenous {beta}3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2425 - H2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Cheng, Z.-S. Zhang, K. Onishi, T. Ukai, D. C. Sane, and C.-P. Cheng Upregulation of Functional {beta}3-Adrenergic Receptor in the Failing Canine Myocardium Circ. Res., September 28, 2001; 89(7): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||